で公開中です! 詳しく見る
5.80 USD
-0.23
3.81%
終値時点 更新済み 10月16日 16:00 EDT
プレマーケット
時間外取引
5.80
0.00
0%
1日
-3.81%
5日間
-9.09%
1か月
-18.08%
3か月
2.29%
6か月
0%
年初来
-50.04%
1年
-50.93%
5年間
-22.97%
10年間
-35.56%
 

概要: LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

従業員数: 150

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 25%
ニュートラル 75%
ネガティブ 0%
ニュートラル
Seeking Alpha
9 日前
Cedar Grove Capital Q3 2026 Portfolio Update
During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. During the quarter, we closed short positions in Bending Spoons SpA, Chipotle Mexican Grill, The Ensign Group, Gemini Space Station, Jersey Mike's Subs, Moderna, Reformation, Once Upon a Farm, and X-Energy Inc. We initiated a small tracking position in Zedcor Inc. while continuing our due diligence.
Cedar Grove Capital Q3 2026 Portfolio Update
ポジティブ
MarketBeat
2 か月前
LENSAR Q2 Earnings Call Highlights
LENSAR NASDAQ: LNSR reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end of the first quarter.
LENSAR Q2 Earnings Call Highlights
ニュートラル
Seeking Alpha
2 か月前
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript
ニュートラル
GlobeNewsWire
2 か月前
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on key operational initiatives.
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
ニュートラル
MarketBeat
5 か月前
LENSAR Q1 Earnings Call Highlights
LENSAR NASDAQ: LNSR executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing on rebuilding commercial momentum around its ALLY femtosecond laser cataract platform. Management said first-quarter results reflected that period of uncertainty, but highlighted continued growth in recurring revenue and rising procedure volumes.
LENSAR Q1 Earnings Call Highlights
ニュートラル
Seeking Alpha
5 か月前
LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript
ニュートラル
GlobeNewsWire
5 か月前
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
ニュートラル
GlobeNewsWire
5 か月前
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
ORLANDO, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company's first quarter 2026 financial results will be released before market open on Friday, May 8, 2026.
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
ニュートラル
Seeking Alpha
6 か月前
LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript
ニュートラル
GlobeNewsWire
6 か月前
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
15 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, 2025
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
価格チャートは Lightweight Charts™ を使用して実装されています